Cargando…

P111: COVID-19 IN PATIENTS WITH THALASSEMIA AND SICKLE CELL DISEASE: A SINGLE CENTER EXPERIENCE

Detalles Bibliográficos
Autores principales:	Dimopoulou, M, Komninaka, V, Flevari, P, Bartzi, V, Repa, K, Voskaridou, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811849/ http://dx.doi.org/10.1097/01.HS9.0000821536.28990.38

Ejemplares similares

5613475 ADVERSE REACTIONS TO RBC TRANSFUSION: A SINGLE THALASSEMIA AND SICKLE CELL DISEASE DEPARTMENT’S EXPERIENCE
por: Xydaki, A.X., et al.
Publicado: (2023)

P116: THE IMPACT OF COVID19 PANDEMIC ON SICKLE CELL MANAGEMENT: EXPERIENCE OF A SINGLE PEDIATRIC CENTER
por: Maria Vousvouki, M, et al.
Publicado: (2022)

P134: THE AREAL PROJECT: A VIRTUAL REALITY APPLICATION TO SUPPORT THE THERAPEUTIC EXPERIENCE AND THERAPY EDUCATION OF ADULT PATIENTS WITH THALASSEMIA AND SICKLE CELL DISEASE
por: Megale, V, et al.
Publicado: (2022)

5610178 SURVIVAL AND COMPLICATIONS IN PATIENTS WITH HEMOGLOBINOPATHIES: THE EXPERIENCE OF A SINGLE DEPARTMENT OF THALASSEMIA AND SICKLE DISEASE
por: Xydaki, X.A., et al.
Publicado: (2023)

P-090: IS A DEDICATED MARKETING APPROVAL OF HYDROXYUREA IN SICKLE CELL DISEASE MAY INCREASE THE CLINICAL BENEFIT OF THE DRUG?
por: F., GALACTÉROS, et al.
Publicado: (2022)

Myocardial iron overload in sickle/thalassemia patients of Italian origin
por: Meloni, Antonella, et al.
Publicado: (2013)

P-083: IMPACT OF ALPHA THALASSEMIA COEXISTENCE ON TRANSFUSION NEED AMONG PATIENTS WITH SICKLE CELL DISEASE
por: A., MADRUGA DE OLIVEIRA LAGROTTA PITTELLA, et al.
Publicado: (2022)

Gaucher-like Cells in Thalassemia Intermedia: Is It a Challenge?
por: Komninaka, Veroniki, et al.
Publicado: (2023)

Endocrinopathies in Thalassemia major patients in Thalassemia Center Jakarta, Indonesia
por: Soesanti, Frida, et al.
Publicado: (2013)

5612535 THE IMPACT OF COVID19 PANDEMIC ON TRANSFUSION DEPENDENT -THALASSEMIA MANAGEMENT: EXPERIENCE OF A SINGLE PEDIATRIC TREATMENT CENTER
por: Maria Vousvouki, M.V., et al.
Publicado: (2023)

PB2544: GAUCHER-LIKE CELLS IN THALASSEMIA INTERMEDIA: IS IT A CHALLENGE?
por: Komninaka, Veroniki, et al.
Publicado: (2023)

P111: It is not in your hands!
por: Damani, N, et al.
Publicado: (2013)

S111: BRAIN PERFUSION CHANGES IN BETA-THALASSEMIA
por: Manara, R, et al.
Publicado: (2022)

P1508: LUSPATERCEPT REDUCES THE BURDEN OF RED BLOOD CELL TRANSFUSION IN PATIENTS WITH BETA -THALASSEMIA AND COMORBIDITIES: THE EXPERIENCE OF A SINGLE THALASSEMIA AND SICKLE CELL UNIT IN A UNIVERSITY HOSPITAL
por: Delicou, S., et al.
Publicado: (2022)

Pregnancy in Thalassemia and Sickle Cell Disease: The Experience of an Italian Thalassemia Center
por: Sorrentino, Francesco, et al.
Publicado: (2020)

5610224 THE USE OF LUSPATERCEPT IN PATIENTS WITH β -THALASSAEMIA AND MULTIPLE SYSTEMIC COMPLICATIONS INCREASES HEMOGLOBIN LEVEL, DECREASES TRANSFUSION BURDEN, AND IS UNAFFECTED BY COMPLICATIONS. SINGLE THALASSEMIA AND SICKLE CELL DEPARTEMENT’S EXPERIENCE.
por: Manganas, K.M., et al.
Publicado: (2023)

Biventricular dimensions and function in pediatric sickle-cell disease and thalassemia major patients without cardiac iron
por: Meloni, Antonella, et al.
Publicado: (2013)

P129: NARRATING SICKLE CELL DISEASE: THE EXPERIENCES OF PATIENTS AND CARGIVERS
por: De Franceschi, L, et al.
Publicado: (2022)

P-055: TRIAL IN PROGRESS: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF THE ERYTHROCYTE PYRUVATE KINASE ACTIVATOR ETAVOPIVAT IN PATIENTS WITH THALASSEMIA OR SICKLE CELL DISEASE
por: T., COATES, et al.
Publicado: (2022)

P-086: POINT-OF-CARE SCREENING FOR SICKLE CELL DISEASE IN RURAL AFRICAN COMMUNITY HEALTHCARE CENTERS
por: C., JAJA, et al.
Publicado: (2022)

P1518: LONG-TERM SAFETY RESULTS OF THE BELIEVE STUDY OF LUSPATERCEPT IN ADULTS WITH ΒETA-THALASSEMIA
por: Viprakasit, V., et al.
Publicado: (2022)

P109: CLINICAL CATEGORIZATION OF CHILDREN WITH SICKLE CELL DISEASE USING SEVERITY SCORE AT A TERTIARY CARE CENTER
por: Dipty Jain, L, et al.
Publicado: (2022)

P110: CLINICAL CHARACTERISTICS OF COVID-19 IN SICKLE CELL DISEASE (SCD) PATIENTS
por: Malhan, H, et al.
Publicado: (2022)

P-036: PIEZO1 ACTIVATION AUGMENTS SICKLING PROPENSITY AND THE ADHESIVE PROPERTIES OF SICKLE RED BLOOD CELLS
por: N., CONRAN, et al.
Publicado: (2022)

P-053: SICKLE CELL MANAGEMENT AND INTERNATIONAL COOPERATION
por: I., DEME LY, et al.
Publicado: (2022)

P-031: TRANSITION FROM LONG TERM HIGH DOSE FULL AGONIST OPIOIDS TO BUPRENORPHINE IN THE INPATIENT SETTING FOR PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: A MODIFIED INDIVIDUALIZED MICRO INDUCTION APPROACH. A SINGLE CENTER EXPERIENCE
por: E., SAAH, et al.
Publicado: (2022)

P-044: RETROSPECTIVE STUDY OF POST-TRANSFUSION ALLOIMMUNIZATION IN THE SICKLE CELL POPULATION OF THE CHR CITADELLE
por: E., SEPULCHRE, et al.
Publicado: (2022)

Osteoporosis in Iraqi patients with thalassemia
por: AL Jadir, Salim M, et al.
Publicado: (2012)

P-094: EXPLORING SCHOOL LIVED EXPERIENCES OF SECONDARY STUDENTS WITH SICKLE CELL DISEASE THROUGH THEIR PARENTS’ LENS
por: C., HARDEN
Publicado: (2022)

P-020: IMPLICATIONS OF SOCIOECONOMIC DISTRESS ON NUTRITIONAL STATUS AND KIDNEY FUNCTION IN PEOPLE WITH SICKLE CELL ANEMIA
por: J., HAN, et al.
Publicado: (2022)

P-019: ENDOTHELIAL ACTIVATION BIOMARKERS FOR THE RISK OF CHRONIC MICROVASCULAR COMPLICATIONS IN SICKLE CELL DISEASE
por: I., AGOUTI, et al.
Publicado: (2022)

P-021: THE LIVING WELL WITH SICKLE CELL MOBILE APPLICATION
por: A., MATTHEWS, et al.
Publicado: (2022)

P121: PREVALENCE OF VERTEBRAL COMPRESSION FRACTURE AND HYPOVITAMINOSIS D IN CHILDREN WITH THALASSEMIA MAJOR
por: Rahmartani, L, et al.
Publicado: (2022)

P-074: NUTRITIONAL AND PUBERTAL PROFILE OF CHILDREN WITH MAJOR SICKLE CELL DISEASE ADMITTED AT THE MEDICAL AND HEALTH COUNCIL CENTER OF CONAKRY, GUINEA
por: M., DIALLO, et al.
Publicado: (2022)

P-097: KNOWLEDGE AND EXPERIENCES OF PARENTS WITH CHILDREN AFFECTED BY SICKLE CELL DISEASE FOLLOWED AT CHUK: A QUALITATIVE STUDY
por: P., HAVUGARUREMA, et al.
Publicado: (2022)

Single center experience in Next Generation Sequencing for genetic diagnosis of Autoinflammatory Disorders (AIDs)
por: Lepri, FR, et al.
Publicado: (2015)

CMR survey in Thalassemia Intermedia patients
por: Meloni, Antonella, et al.
Publicado: (2014)

P-005: COMPARISON OF SICKLE SCAN AND HEMOTYPE SC AS POINT-OF-CARE NEWBORN SCREENING DIAGNOSTICS FOR SICKLE CELL DISEASE IN LUANDA, ANGOLA
por: B., SANTOS, et al.
Publicado: (2022)

P-063: NUTRITIONAL AND PUBERTAL PROFILE OF CHILDREN WITH MAJOR SICKLE CELL DISEASE ADMITTED AT THE MEDICAL AND HEALTH COUNCIL CENTER OF KIPÉ, CONAKRY-2018
por: M., DOUKOURE, et al.
Publicado: (2022)

5596911 RETINAL AND MACULAR AFFECTION IN EGYPTIAN SICKLE CELL DISEASE PATIENTS USING SPECTRAL DOMAIN OCT AND OCT-ANGIOGRAPHY: A SINGLE CENTER STUDY
por: El-Ghamrawy, M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_df89o2tukmk6nj32s66nvtdhq7